Trial intelligence / Profile preview

Ciprofol versus propofol for general anesthesia in thoracoscopic surgery

ChiCTR2400086976Phase 3Completed

Sponsor
Zhejiang Cancer Hospital
Start
Jul 2024
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of ciprofol and propofol in lung neoplasm (2 arms), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Success rate of induction and maintenance of general anesthesia. Started Jul 2024; status: completed.

02

Drugs

ciprofolpropofol
03

Conditions

lung neoplasm

Beyond the preview

Go deeper on ChiCTR2400086976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400086976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call